ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026
Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.
Nadine Tung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.